CA 19-9 doubling time in pancreatic cancer as a predictor of venous thromboembolism: a hospital database study

Authors

  • Maija H. Peippo Institute of Biomedicine, Research Center for Cancer, Infections and Immunity, University of Turku, Turku, Finland; Department of Oncology, Tampere University Hospital, Tampere, Finland
  • Samu Kurki Auria Biobank, University of Turku and Turku University Hospital, Turku, Finland
  • Hanna Seppänen Department of Surgery, Translational Cancer Medicine Research Program, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
  • Riitta Lassila Department of Hematology and Comprehensive Cancer Center, Unit of Coagulation Disorders, and Research Program in Systems Oncology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
  • Olli Carpén Institute of Biomedicine, Research Center for Cancer, Infections and Immunity, University of Turku, Turku, Finland; Department of Pathology, Medicum and Research Program in Systems Oncology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

DOI:

https://doi.org/10.1080/0284186X.2019.1679881

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2020-02-01

How to Cite

Peippo, M. H., Kurki, S., Seppänen, H., Lassila, R., & Carpén, O. (2020). CA 19-9 doubling time in pancreatic cancer as a predictor of venous thromboembolism: a hospital database study. Acta Oncologica, 59(2), 237–241. https://doi.org/10.1080/0284186X.2019.1679881

Issue

Vol. 59 No. 2 (2020): Acta Oncologica

Section

Articles